Intercept Pharmaceuticals, Inc.

254900JMB8TX5P688V24

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: September 4, 2002

Address

Country: United States
Legal address: c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange St19801 WilmingtonUnited States (US-DE)
Head office: 305 Madison Avenue07960 MorristownUnited States (US-NJ)

Identifier

LEI: 254900JMB8TX5P688V24
Registered: September 24, 2021 at 11:55 AM UTC
Last updated: September 24, 2023 at 01:30 PM UTC
Next renewal: September 24, 2023 at 11:55 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 3565213
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 3565213
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/254900JMB8TX5P688V24This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search